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ABSTRACT 
Mitochondria-associated membranes (MAMs) are structures that regulate physiological functions 
between endoplasmic reticulum (ER) and mitochondria in order to maintain calcium signaling and 
mitochondrial biogenesis. Several proteins located in MAMs, including those encoded by PARK genes 
and some of neurodegeneration-related proteins (Huntingtin, Presenilin, etc.) ensure this regulation. In 
this regard, MAMs alteration is associated with neurodegenerative diseases such as Parkinson (PD), 
Alzheimer (AD) and Huntington diseases (HD) and contributes to the appearance of the pathogenesis 
features, i.e. autophagy dysregulation, mitochondrial dysfunction, oxidative stress and lately neuronal 
death. Moreover, ER stress and/or damaged mitochondria can be the cause of these disruptions. 
Therefore, ER-mitochondria contact structure and function are crucial to multiple cellular processes. This 
review is focused on the molecular interaction between ER and mitochondria indispensable to MAM 
formation and on MAM alteration-induced etiology of neurodegenerative diseases. 
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1.- ASSOCIATIONS BETWEEN MITOCHONDRIA AND OTHER 
ORGANELLES  
Eukaryotic cells contain membrane-bound organelles with unique identities and specialized 
functions.  Communication and cooperation between these organelles take place in order to maintain a 
variety of physiological functions. This communication requires the formation of specialized membrane 
microdomains at the contact sites, defining short distances between membranes to connect them, and 
allowing ions, metabolites and lipids exchange.  
The best-characterized inter-organelle connection involves mitochondria and a specialized 
domain of the endoplasmic reticulum (ER), known as the mitochondria associated-membrane (MAM).  
ER-mitochondria contacts sites have been demonstrated to act as a signaling hub, playing a crucial role in 
lipid metabolism and calcium (Ca2+) homeostasis, therefore regulating fundamental processes for the cell, 
such as mitochondrial morphology [1,2], ROS (reactive oxygen species) induced-cell stress [3], 
autophagy [4] and apoptosis (Reviewed  elsewhere in [5]). Notably, several recent studies indicate that 
perturbations in the ER-mitochondrial network might underlie the pathogenesis of several 
neurodegenerative diseases [6,7] (see below). Therefore, the interest on mapping ER-mitochondria 
connections has risen considerably and current research is focused on determining their function, 
regulation and (patho) physiological consequences.   
Mitochondria are known to communicate also with other organelles, although these interactions 
are less characterized at the molecular level than those with the ER. The recruitment of membranes to 
mitochondria is mediated through the formation of molecular tethers. Several protein complexes residing 
in mitochondria and other organelles have been identified as molecular tethers with new properties and 
functions. These proteins include various chaperones, protein kinases, mitochondria-shaping proteins, 
sorting proteins, etc.  Contact sites between the endosomal system and mitochondria have been observed 
in reticulocytes [8]. Likewise, melanosomes-mitochondria contacts have also been described [9]. These 
particular contacts may be related to an additional metabolic demand, such as iron delivery or a higher 
energetic demand, but it is possible that also applies to other mammalian cells. In S. cerevisiae, 
mitochondria are found to be closed to the contact of vacuoles by the vCLAMP (vacuole–mitochondrial 
patch) (Reviewed in [10]). Although interaction between mitochondria and lipid droplets or peroxisomes 
has been reported in some cell types [11,12], it remains unknown whether this interaction allows 
exchange of metabolites between them [13]. Recently, a mitochondria–plasma membrane tethering 
complex has been described in yeast, the Num1/Mdm36 (nuclear migration 1/mitochondrial distribution 
and morphology 36) complex [14,15]. This interaction has important functions during cell division and it 
supports mitochondrial division, however yeast homologs of the tethering complex are unknown in 
metazoan model systems.  
2.- MITOCHONDRIA-ASSOCIATED MEMBRANES (MAMs)  
Association between the ER and mitochondria was the first described inter-organelle contact. In 
early 60s, Copeland and Dalton demonstrated this connection by electron microscopy in the 
pseudobranch gland of a teleost [16]. Nearly twenty years later, several groups confirmed these findings 
using different microscopy techniques and co-sedimentation experiments [17,18]. Ten years later, 
fractionation studies by Jean Vance termed the biochemically distinct domains of the ER that are in close 
contact with mitochondria as MAM [19]. This and other earlier studies proposed MAMs (mitochondria-
associated membranes) as a platform for lipid synthesis and transfer between ER and mitochondria [20-
23]. Actually, the first proteins identified on the MAMs, PEMT2 (phosphatidyl ethanolamine 
methyltransferase 2) and PSS1/2 (phosphatidylserine synthase 1 and 2) [24,25], are associated with lipid 
metabolism, and FACL4 (fatty acid CoA ligase 4), which is involved in triacylglycerol synthesis, is 
currently considered one of the most reliable MAM marker proteins [26].  
Subsequent studies by Rizzuto and co-workers showed that these structures are also involved in 
Ca2+ homeostasis, demonstrating Ca2+ transfer from ER to mitochondria in hotspots by live-cell imaging 
studies [27-29]. Besides, they showed that this exchange due to 5-20% of the mitochondrial surface is 
closely opposed (10-25 nm) to ER membranes [27]. Thus, MAMs can act as a Ca2+ signaling hub that 
accommodate the Ca2+ transfer from the ER to mitochondria in order to maintain cellular bioenergetics 
and mitochondrial dynamics, or to promote cell death [30,31]. The enrichment of the Ca2+ channel IP3R 
(inositol-1,4,5-trisphosphate (IP3) receptor) on the MAMs supports this model [32,33]. IP3R contacts the 
outer mitochondrial membrane (OMM) protein VDAC1 (voltage-dependent anion channel isoform 1) 
through the molecular chaperone GRP75 (glucose-regulated protein 75), allowing Ca2+ transfer from the 
ER to mitochondria. Thus, it has been proposed that GRP75 acts as a bridge between them [29], 
strengthening the functional ER-mitochondria interaction by forming a tether complex with IP3R (ER) 
and VDAC1 (mitochondria). Nevertheless, loss of IP3R does not interfere in ER-mitochondria 
association, which argues against a physical tethering role for this Ca2+ channel [34]. 
ER-mitochondria contact sites are enriched with proteins that are involved in MAMs functions. 
In addition to the IP3R-GRP75-VDAC1 complex, other MAMs proteins were proposed to act as 
molecular tethers as well, linking physically the ER to the mitochondria. In yeast, ER-mitochondria 
connection is mediated by the ER-mitochondria encounter structure (ERMES) complex, which is 
composed of the ER protein Mmm1 (mitochondrial morphology protein 1) and the mitochondrial proteins 
Mdm10 (mitochondrial distribution and morphology protein 10), Mdm34, Mdm12 and Gem1 (GTPase 
EF-hand protein of mitochondria 1) [35]. This complex is also involved in lipid transfer and 
mitochondrial fission [36]. However, ERMES machinery has not yet been identified in mammalian cells 
yet. Electron microscopy and tomography studies have determined the presence of tethers of different 
sizes, suggesting that this contact may rely on different protein complexes in rat liver mitochondria and 
DT40 cells [34]. In addition, both rough and smooth ER form contacts with mitochondria in HT-1080 
fibrosarcoma cells, indicating that selective recruitment of different domains of ER might depend on 
different tethering complexes and that several types of MAMs might exist  [34,37]. MAMs proteins, such 
as PACS-2 (phosphofurin acidic cluster sorting protein-2) [38] and MFN2 (mitofusin 2) [39], have been 
implicated in the regulation of MAMs’ formation and functions. PACS-2, a cytosolic sorting protein, 
regulates localization of the ER chaperone calnexin (CNX) and the Ca2+ channel TRPP2 (transient 
receptor potential protein 2) at MAMs [38,40,41]. These studies reported that PACS-2 down-regulation 
uncouples mitochondria from the ER. Nevertheless, it remains unknown whether this is a result of 
mitochondrial fragmentation, also observed in this study [38]. MFN2 is a dynamin-related protein that 
mediates, together with MFN1 (mitofusin 1) and OPA1 (optic atrophy 1), mitochondrial fusion.  
Furthermore, MFN2 is widely accepted as a regulator of the ER–mitochondria crosstalk by forming 
homotypic interactions and heterocomplexes with its homolog MFN1. However, this model has been 
recently challenged by different reports [37,42,43]. In fact, MFN2 ablation increased ER–mitochondria 
coupling, indicating that it plays a role as an ER–mitochondria tethering antagonist [37,42,43]. Finally, a 
novel tethering complex composed by the integral ER protein VAPB (vesicle-associated membrane 
protein-associated protein B) and the OMM protein PTPIP51 (protein tyrosine phosphatase-interacting 
protein 51) has been reported [44,45]. VAPB is enriched at MAMs and binds to PTPIP51 at MAMs. This 
interaction forms a molecular scaffold which tethers ER regions to mitochondria, regulating MAM 
functions, like the Ca2+ exchange between the two organelles [45,44,46]. 
 
3.- FUNCTIONAL ROLE OF THE MAMs 
As we previously stated, MAMs are involved in several biological processes. Hereafter we will 
show what is known about its role and regulation in such processes. Table 1 summarizes all old and new 
findings related to MAMs biology.  
3.1.- MAM is essential for mitochondrial morphology 
Several proteins involved in mitochondrial movement along microtubules, such as dynein and 
kinesin, are tightly regulated by Ca2+-sensors [47-49]. Mitochondrial movement is modulated by the 
cytosolic Ca2+ content. Its rise blunts the mitochondrial motility that can be recovered by EGTA 
(Ethylene glycol-bis(2-aminoethylether)-N,N,N′,N′-tetraacetic acid) incubation or physiological Ca2+ 
level [49]. Evidence has demonstrated that reversible inhibition of mitochondrial motility, in Vasopressin 
(a Ca2+ mobilizing)-or Ionomycine (a Ca2+ ionophore)-treated cells, is related to the IP3-IP3R pathway- 
mediated Ca2+ [49]. Reduced mitochondrial motility induces an increase in their association to the 
MAMs, subdomains of high Ca2+ release, thus enhancing their Ca2+ uptake and buffering capacity 
[49,50]. Miro family of proteins (Miro1 and 2) is one of the master regulators of mitochondrial motility, 
based on local Ca2+ levels. It has been shown that these proteins have an important role in tethering the 
mitochondria to the cytoskeleton by binding kinesin, thus leading to the movement of this organelle 
[51,52].  
Beyond the regulation of mitochondrial motility, MAMs participate in the regulation of 
mitochondrial morphology [1]. Mitochondria are dynamic organelles, continuously undergoing fusion 
and fission. An appropriate balance between these two opposing processes is crucial for cell survival [53], 
as well as to maintain the shape, the size and the number of mitochondria [54,55]. Then, this balance is 
highly regulated and its defect leads to fragmented networks. Indeed, mitochondrial fragmentation is a 
process often stimulated in response to cellular stress [54]. The main mitochondrial fission and fusion 
proteins are dynamin-related proteins (DRP). Recruitment of DRP1 from the cytoplasm to the 
mitochondria is a key step in fission regulation.  In 2011, Friedman and co-workers demonstrated that 
mitochondrial fission occurs at positions where ER tubules contact and constrict mitochondria. These 
constrictions would facilitate DRP1 recruitment [1]. Other proteins like Mff (mitochondria fission factor) 
and Fis1 (fission 1 protein) are important for DRP1 recruitment to mitochondrial fission sites and both 
proteins have also been localized to the MAM [56]. However, Mff localizes in a DRP1-independent 
manner to mitochondrial constrictions at sites of ER contact [56]. Recently, syntaxin 17 have been 
involved in mitochondria fission. This protein is present at the ER-mitochondria contact sites where 
interacts with Drp1 and modulates the mitochondria fission by regulating Drp1 activity and localization 
[57]. Therefore, all these findings suggest that the recruitment of the mitochondrial fission machinery to 
the MAMs is crucial for mitochondrial morphology. 
 
3.2.- ER-mitochondria contact sites are involved in autophagosome biogenesis 
Autophagy is a cellular response in which cytosolic components and damaged organelles, but 
also invading pathogens, are engulfed in double-membrane vesicles and delivered to lysosomes for their 
degradation [58]. The origin of the autophagosomal membrane is still controversial. Several cellular 
compartments have been pointed as potential membrane sources [59-62]. A recent study by the group of 
T. Yoshimori reported that ER-mitochondria contacts sites are involved in phagophore assembly. Upon 
autophagy induction, the pre-autophagosome marker ATG14L (autophagy-related 14-like) and DFCP1 
(double FYVE domain-containing protein 1), a marker of the omegasome, relocalize to the MAMs to 
initiate autophagosome formation [4]. Moreover, autophagosome-formation marker ATG5 (autophagy-
related 5), also shifts to the MAMs after starvation [4]. Interestingly, syntaxin 17 also participates in the 
autophagosome formation through its interaction with ATG14L promoting the recruitment of PI3P 
(phosphatidylinositol 3-phosphate) complex [57]. In contrast, the disruption of ER-mitochondria contact 
sites reduced the number of autophagosomes. Taken together, these results underscore the importance of 
MAMs in the biogenesis of autophagosome through the recruitment of autophagy-related proteins to the 
ER-mitochondria contact sites.  
Besides its role in autophagosome biogenesis, MAM is important for mitophagy in yeast [63]. 
Mitophagy is a selective autophagy that removes damaged mitochondria [64]. Bökler and Westermann 
have described that mitochondria-ER contact sites are crucial for mitophagy. In yeast, mitochondrial ER 
tethering is mediated by ERMES complex.  Defects in ERMES complex have strongly reduced rates of 
mitophagy [63]. Therefore, the mitochondria-ER contact sites have an active role in the initial steps of 
both autophagy and mitophagy in mammalian and yeast model, respectively. 
The mTOR (mammalian Target of Rapamycin) kinase is also localized to the ER and 
mitochondria. The mTOR kinase is a negative regulator of autophagy and forms two functionally and 
structurally distinct complexes: mTORC1 and mTORC2 (mTOR complex 1 and 2) [65]. It has been 
reported that the localization of mTORC2 to MAMs is a growth factor-dependent signaling, regulating 
MAMs integrity and mitochondrial function via Akt [66]  
3.3.- Ca2+ transport through MAM regulates important cellular processes. 
Initial studies on intracellular Ca2+ signaling reported that ER and mitochondria could be 
functionally linked [67]. Although the ER is the major Ca2+ storage unit in the cell, mitochondria are also 
important Ca2+ reserve. However, resting mitochondrial Ca2+ concentrations are significantly low (in the 
range of hundreds of nM) and it is only when cytosolic Ca2+ concentrations are above µM that 
mitochondria can take up Ca2+ to reach the intramitochondrial levels of µM ranges [68]. 
Currently, we know that cyclical Ca2+ exchange between ER and mitochondria is essential for 
cellular viability. ER Ca2+ determines the correct activity of numerous ER-resident enzymes involved in 
the generation of secretory proteins, like CNX and calreticulin (CRT) [69]. Simultaneously, both 
chaperones interact with the MAM-enriched IP3R and ER Ca2+ transport ATPase (SERCA) 2b, regulating 
ER–mitochondria Ca2+ flux [70,71]. Palmitoylated CNX interacts at the MAMs with SERCA2b to 
regulate Ca2+ signaling, whereas non-palmitoylated CNX mainly acts in the rough ER to mediate protein 
folding and quality control [72]. The ER protein Sig-1R (sigma-1 receptor) also localizes at the ER–
mitochondria junction and can be considered as a bona fide MAM marker [73]. Sig-1R forms a Ca2+-
sensitive chaperone complex with BiP/GRP78 (binding immunogobulin protein/ glucose regulated 
protein 78) and prolongs Ca2+ signaling from the ER to the mitochondria by stabilizing IP3R subunit 3 at 
MAMs [73]. Moreover, IP3R interacts with VDAC1 at the OMM through GRP75, a chaperone located in 
MAMs, facilitating the Ca2+ uptake from ER to mitochondria [29]. VDAC1 selectively transfers apoptotic 
Ca2+ signals to mitochondria because of its Ca2+-binding sites. This Ca2+-permeability (increase of 
mitochondrial Ca2+) favors VDAC1 oligomerization and triggers apoptotic cell-death by cytochrome c 
release [74].  In fact, GRP75 is a scaffold that would determine the ER-mitochondria contacts. The down-
regulation of GRP75 abrogates the functional interaction between IP3R and the mitochondria, altering the 
normal transfer of Ca2+ to the mitochondria [29]. Indeed, overexpression of VDAC1 has been shown to 
promote Ca2+ uptake into mitochondria [75]. Taken together, all these studies suggest that chaperone 
complexes at both the ER and the mitochondrion could coordinate Ca2+ regulation between these two 
organelles. 
Furthermore, the transfer of Ca2+ from ER to mitochondria is crucial for mitochondrial function. 
ATP production is regulated by Ca2+ transfer from the ER as several mitochondrial dehydrogenases of the 
Krebs cycle are directly monitored by Ca2+ [76]. Increased ER-mitochondria communication is predicted 
to lead to mitochondrial Ca2+ overload, which could induce opening of the mitochondrial permeability 
transition pore, triggering apoptosis [5]. The most important Ca2+ channel responsible for Ca2+ release 
from ER to mitochondria is the IP3R, which is highly concentrated in ER-mitochondrial contact sites. It 
has been shown that IP3R activity is modulated by several interacting proteins [30,31]. In fact, it has been 
shown that cytochrome c binds to IP3R channels during apoptosis, blocking the Ca2+-dependent inhibition 
of IP3R function and promotes apoptotic Ca2+ release [30]. Indeed, PTEN (phosphatase and tensin 
homolog) has also been reported to be located at the MAMs and enhances Ca2+ signaling to the 
mitochondria in situations of increased ER stress and pro-apoptotic signaling [77]. Moreover, during 
apoptosis, mitochondrial fragmentation increases due to the recruitment of the fission protein DRP1 to the 
OMM. In this particular location, DRP1 also stimulates BAX (Bcl2-associated X protein, a pro-apoptotic 
OMM protein) to form oligomeric pores that cause OMM permeabilization (OMMP), causing the release 
of cytochrome c and other pro-apoptotic factors to the cytosol [55]. Conversely, when mitochondrial 
fusion is increased, apoptosis is attenuated. 
Interestingly, the disruption of MAMs by PACS-2 depletion induced apoptosis [38]. PACS-2 is a 
MAM-associated multi-functional sorting protein required for extrinsic and intrinsic apoptosis. The 
absence of PACS-2 was reported to induce UPR (unfolded protein response) and mitochondria 
fragmentation and BAP31 (B-cell receptor associated protein 31)-mediated apoptosis [38]. 
Ca2+ depletion and accumulation of unfolded or misfolded proteins in the ER lumen elicit ER 
stress. Under these conditions, three proteins located in the ER membrane PERK (protein kinase RNA-
like ER kinase) [78], IRE1 (inositol-requiring protein 1) [79] and ATF6 (activating transcription factor 6) 
[80] act as specialized stress sensors, starting UPR. These proteins are able to activate signaling pathways 
which involve ER-resident chaperones, including BiP/GRP78 and the lectins CNX and CRT [81], to 
mitigate and buffer ER stress, and finally recover the ER functionality. Moreover, protein folding requires 
high levels of energy, thus ER homeostasis is tightly regulated. This specialized ER-redox environment is 
maintained by oxidoreductase enzymes. Some members of this group are PDI (protein disulfide 
isomerase) and Ero1 (ER oxidoreductase 1) which are implicated in the formation of disulfide bonds [82].  
During early phases of ER stress, ER–mitochondrial connection is enriched in the perinuclear 
zone of cells [83]. In this cellular context, it would be feasible that connections between ER and 
mitochondria participate in the regulation of ER stress.  
Indeed, it has been shown that PERK is enriched at the MAMs, being required for the regulation 
of inter-organellar communication during ROS-induced cell death [84]. Furthermore, genetic ablation of 
PERK deficiency decreased mitochondrial Ca2+ uptake, conferring mitochondrial protection against ER 
stress-mediated apoptosis by the reduction of caspase activation and cytochrome c release [84]. A recent 
study by the group of Zorzano reported that the mitochondrial protein MFN2 physically interacts with 
PERK and this binding is required for the proper regulation of cellular homeostasis upon ER stress [85].   
BiP/GRP78, apart from its role in protein folding, is involved in Ca2+ buffer in the ER lumen 
[86]. In this regard, it has been shown that BiP forms a complex with the ER protein Sig-1R, to control 
the mitochondrial Ca2+ signaling at MAM. These authors observed that ER stress induction by TG 
(thapsigargin, an inhibitor of the sarco-endoplasmic reticulum Ca2+- pump) treatment induces dissociation 
between BiP and Sig-1R, and the translocation of Sig-1R from the MAM to other ER regions [87]. As 
mentioned before, another ER-resident chaperone, CNX, is also enriched at the MAM after 
palmitoylation [88], suggesting that this mechanism could mediate protein re-localization to these cellular 
hubs. Related to this, it has been shown that the cytosolic sorting protein PACS-2 is also responsible for 
the CNX enrichment at the MAMs [89].  
Other studies have revealed that Ero1α, one of the two mammalian isoforms of Ero1, 
accumulates at the MAMs during oxidizing and normoxic conditions [90] and modulates Ca2+ fluxes [91]. 
Nevertheless, we cannot exclude that this Ero1α enrichment is linked to other specific functions at the 
ER-mitochondria interface.  
Taken together, all these findings demonstrate that MAMs regulate the Ca2+ flux between the ER 
and mitochondria through the accumulation of Ca2+ signaling proteins in the MAMs compartment. Higher 
Ca2+ transfer from ER to mitochondria mediates mitochondrial Ca2+ overload that induces mitochondria 
dysfunction and apoptosis. However, the disruption of ER- mitochondria association decreases the flux of 
Ca2+ between these two organelles and reduces cell viability. Moreover, perturbations of ER-
mitochondria contact sites induce ER stress. Therefore, MAMs play a key role of Ca2+ signaling inducing 
processes such as ER stress and apoptosis.   
 
 
3.4.- Role of MAM in inflammatory response induced by ROS 
In 2011, the group of Tschopp observed that ROS promoted NLRP3 (Nod-like receptor family, 
pyrin domain containing 3) inflammasome activation, linking ER–mitochondria interface and 
inflammation [92].  
The inflammasome is a multiprotein complex of the innate immune response that regulates the 
activation of caspase-1 and triggers the processing and maturation of proinflammatory cytokines such as 
IL-1β (interleukin-1β) and IL-18 [93,94]. There is a whole family of inflammasomes, NLRP3 
inflammasome is the most thoroughly characterized and comprises the NLRP3 protein, the adapter 
apoptosis-associated speck-like protein (ASC) and pro-caspase-1. [95] Upon MSU (monosodium urate) 
and, in particular, nigericin addition, NLRP3 co-localizes with ASC proteins at the MAM fraction and 
ASC translocation to the MAMs seems to be NLRP3-dependent [92]. 
The generation of mitochondrial ROS appears to be common to many activators of the NLRP3 
inflammasome [96]. As mentioned before, VDAC1 are important regulators of mitochondrial metabolic 
activity through the uptake of Ca2+ into the mitochondria from MAMs. It has been described that VDAC1 
is ultimately required for mitochondrial ROS production. In this regard, the downregulation of VDAC1 
significantly impairs NLRP3 inflammasome activation [92]. The critical role of MAMs in NLRP3 
inflammasome activation is still unclear. However, all these findings suggested the crucial role of the 
MAMs in the coordination of cell non-autonomous functions, like inflammation. 
Moreover, another NLRP3 binding partner, TXNIP (Thioredoxin-interacting protein), activates 
the NLPR3 inflammasome under mitochondrial oxidative stress condition to mediate inflammatory 
response in primary rats hepatocyte [97] as well as in THP1 macrophage cells [92]. In fact, TXNIP is 
mainly expressed in the nucleus under normal physiologic condition. In H2O2-treated β pancreatic cells, it 
has been demonstrated the translocation of TXNIP from the nucleus to mitochondria. This translocation 
makes cells vulnerable to oxidative stress as TXNIP binds to the thioredoxine-2 [98]. Of note, NLRP3 is 
found to reside principally in ER together with the CRT ER marker. NLRP3 moves on the ER-
mitochondria contact site resulting from inflammasome activation by MSU or nigericin treatment [92]. 
Thus, it thought that ROS production increases TXNIP expression that provokes NLRP3 inflammasome 
activation. Interestingly, antioxidant treatments mitigate NLPR3 activation-induced ROS-TXNIP 
pathway [97]. These results suggest that MAMs have an important role in initiating the inflammatory 
response to oxidative stress. 
 
3.5.- Regulation of antiviral signaling by ER-mitochondria contact sites. 
Cytokines, and their corresponding cellular receptors, play a role during the inflammasome 
activation, but are also involved in the antiviral response. Basically, the first line of defence of the innate 
immune system is the pathogen recognition by PRR (pattern recognition receptor) proteins, which detect 
specific molecular signs of the pathogen, called PAMP (pathogen-associated molecular pattern) and 
activates the antiviral signaling pathway. Intracellular double stranded RNA (dsRNA) is a viral 
replication signature and is considered as a PAMP.  
The RNA helicase RIG-I (retinoic acid inducible gene I) recognizes dsRNA, triggering innate 
antiviral response [99]. RIG-I also contains 2 CARDs (caspase activation and recruitment domains) in the 
N-terminal region, which are accessible for Lys63-linked ubiquitination by TRIM25 (tripartite motif 
containing 25) upon interaction of non-self-cytosolic RNA [100]. Once RIG-I is activated, it triggers host 
response signaling, including type I interferon (IFN) expression [101]. During virus infection, RIG-I 
senses dsRNA as non-self and is recruited to its adaptor protein MAVS (mitochondrial antiviral-signaling 
protein; also called VISA, IPS-1 or Cardif), initiating the cellular antiviral response [102]. Interestingly, 
this transmembrane protein is localized to both peroxisomes and mitochondria [103,104], as well as to the 
MAMs [105]. The specific location of the complex RIG-I and MAVS at the MAM is driven by the 
tethering factor MFN2 [105]. 
In addition, Hepatitis C virus (HCV) is sensed by RIG-I [106], however this virus uses its 
NS3/4A protease to cleave MAVS, avoiding antiviral induction [107]. Interestingly, NS3/4A is able to 
process MAM-associated MAVS, but not mitochondrial-associated MAVS [105], indicating that MAVS 
subpopulation located at this certain cellular hub is critical for the antiviral signaling against HCV [108]. 
Recently, the group of Michael Gale Jr. has identified, by proteomic analysis, MAM localization of new 
proteins during RNA virus replication, such as RAB1B (member RAS oncogene family 1B), VTN 
(vitronectin) and LONP1 (Lon Peptidase 1) [109]. Therefore, the importance of the MAMs in the innate 
immune response to RNA viruses would rely on its function as a key cellular platform, contributing to the 
dynamic re-localization of protein complexes to initiate antiviral signaling. 
 
 
3.6.- Involvement of MAM in lipid metabolism 
Lipid synthesis, including triacylglycerol, PC (phosphatidylcholine) and PE 
(phosphatidylethanolamine), requires enzymatic activity associated with both the ER and mitochondria. 
Phosphatidylserine (PS) is formed from PC by PSS1 in MAM and is converted to PE by PS 
decarboxylase in mitochondria. Interestingly, one of the final enzymes implicated in PC synthesis, 
PEMT2 (phosphatidylethanolamine N-methyltransferase 2) [110], was found to be restricted to the 
MAMs [25]. Moreover, other studies demonstrated that PC synthesis requires a tightly regulated lipid 
transfer between the ER and mitochondria, thus confirming earlier hypothesis [111]. Acyl-CoA: 
diacylglycerol acyltransferase 2 (DGAT2) is also located at ER-mitochondrial contact site. It catalyzes 
triacylglycerol synthesis and promotes lipid droplet formation [112]. DGAT2 has a mitochondrial-
targeting signal that promotes its association with mitochondria [112]. However, the MAM enrichment 
mechanism for PEMT2 and PSS1 is still not understood. 
MAM contains other lipid metabolism enzymes identified as MAM markers such as FACL4, 
which mediates the ligation of fatty acids to coenzyme A [113] and Acyl-Coenzyme A:cholesterol 
acyltransferase 1 (ACAT1/SOAT1). The enzymatic activity of ACAT1/SOAT1 is the most enriched in 
this specific cellular location [26], acting as a multimembrane-spanning enzyme that catalyzes the 
production of cholesterol esters, which are subsequently incorporated into lipid droplets. 
Therefore, the transport of lipids between the ER and mitochondria, and the accumulation of 
lipid metabolism enzymes on the MAMs are crucial for lipid metabolism [26]  
4.- ROLE OF MAMS IN SEVERAL NEURODEGENERATIVE DISORDERS  
As discussed above, MAMs play a crucial role in several signaling pathways and metabolic processes, 
including lipid metabolism, autophagy regulation and mitochondrial physiology, among others. Many of 
these functions are disrupted in several neurodegenerative diseases. Indeed, alterations in ER-
mitochondria associations have been reported in Parkinson’s disease (PD) and other neurodegenerative 
disorders that are deeply commented below (Figure 1). Most of the findings related to the role of MAMs 
in neurodegenerative diseases are included in Table 2. Neurodegenerative diseases are characterized by 
the accumulation of proteins that are somehow the main inducer of inflammatory response and 
consequently ER stress. It is well known that ER is required for the MAM formation and its 
morphological alteration can affect MAM function. Firstly, it is difficult to speculate whether MAM 
dysregulation is the cause or consequence of neurodegenerative disorders. However, it is clear that such 
dysfunction participates in the acceleration of neuronal death.  
 
4.1.- Alzheimer’s disease (AD) 
The AD-related proteins PS1 and PS2 (Presenilin-1 and -2) are highly located in the MAMs. PS1 
and PS2 are components of the γ-secretase complex that processes the amyloid precursor protein (APP), 
releasing the toxic β-amyloid peptide (Aβ) [114]. Their localization at MAM may explain the 
mitochondrial oxidative damage associated with abnormal APP processing and Aβ accumulation in 
mitochondria.  In this sense, mutations in PS1, PS2, and APP have been shown to upregulate ER-
mitochondria associations and intensify mitochondrial Ca2+ uptake. In fact, in both familial and sporadic 
AD, the interactivity of ER-mitochondria is upregulated, as well as MAMs function [6]. Lines of 
evidence point to the increasing expression of MAM-associated proteins in postmortem AD and in a 
APPswe/lon mouse model of AD, and protein upregulation, including PACS-2, VDAC1 and IP3R, is 
inherent to new ER-mitochondria contacts [7]. However, this overexpression is not observed in an APParc 
mouse model, possibly because of the milder pathology of this model compared to the other one [7]. As 
the latter model has an intra Aβ mutation instead of mutations in β and γ cleavage sites of the former, this 
finding suggests an interaction between Aβ proteins and MAMs that should be further addressed. In spite 
of this upregulation of MAMs in AD patients, decreased levels of the ER protein Sig-1R were reported in 
a postmortem hippocampus of AD patients [115]. 
4.2.- Amyotrophic lateral sclerosis (ALS) 
Sig-1R is an ER chaperone protein, located in MAM and mitochondria, as it was previously 
mentioned. ER stress causes a shift of Sig-1R from MAM [116] toward ER region. Loss of function (by 
gene mutation or down-regulation) of Sig-1R is responsible for several forms of ALS. The gene mutation 
E102Q, located in the transmembrane domain of the corresponding protein, was found in a juvenile ALS 
form [117]. 
As Sig-1R, the ALS-related VAPB protein is also localized in the MAMs. As mentioned before, 
VAPB interacts with the OMM protein PTPIP51 (protein tyrosine phosphatase-interacting protein-51) 
[45]. Mutated VAPB-P56S has been found to increase its affinity to bind to PTPIP51 and consequently, 
increases Ca2+ transfer into mitochondria.  VAPB mutation could also affect lipid transfer due to its 
ability to interact with other ER proteins, like OSBP (oxysterol binding protein). Indeed, it was shown 
that mutant VAPB prevents the ER localization of OSBP, as well as reduction of phosphoinositides [118]. 
Furthermore, ALS-associated TDP-43 (TAR DNA-binding protein-43) reduces the VAPB-PTPI51 
interaction by GSK-3β (glycogen synthase kinase-3 beta) activation, disrupting ER-mitochondria 
association [45].  
4.3.- Huntington’s disease (HD) 
Huntingtin protein, whose polyglutamine repeats mutation is implicated in Huntington’s disease 
(HD), has been found to be an ER-associated protein [119]. Its presence is important for ER morphology, 
but overexpression of mutant huntingtin elicits cell death in PC6.3 neuronal cell by generating ER stress 
[120]. While ER stress or UPR is activated, huntingtin protein shuttles from ER to the nucleus. 
Polyglutamine-expanded huntingtin triggers ER stress because of protein aggregates formation and 
upregulates BiP/GRP78, CHOP (C/EBP homologous protein), PDI and Sig-1R protein levels [116]. 
Although Sig-1R is important for UPR regulation during ER stress, it is shown to be decreased in several 
neurodegenerative disorders, including AD, HD and Parkinson’s disease (PD) [121,122]. The reason of 
such reduction may be due to its capacity to bind protein aggregates in neurodegenerative diseases [116]. 
Interestingly, in a HD cell model, Sig-1R levels were reestablished by the agonist receptor and, 
subsequently, mutant huntingtin toxicity was prevented [116]. Indeed, mutant huntingtin impairs the ER-
associated degradation (ERAD) and vesicle trafficking [123], that favor proteins inclusions. As long as 
ER stress is activated, Ca2+ transfer from the ER to mitochondria is deregulated through MAM interface. 
4.4.- Neuronal ceroid lipofuscinosis (NCL)  
Ceroid-lipofuscinosis neuronal 3 (CLN3) is a lysosomal transmembrane protein whose mutation is 
implicated in the infantile neurodegenerative disease, neuronal ceroid lipofuscinosis (NCL) [124]. It was 
reported that the yeast homolog of CLN3, BTN1 (battenin CLN3 family protein), plays a crucial role in 
phospholipids distribution between ER and mitochondria. BTN1 deletion decreases PS transfer from ER 
to mitochondria as well as impairs PE levels in the MAMs [125]. 
5.- INVOLVEMENT OF MAMs IN PARKINSON’S DISEASE (PD) 
Mitochondria dysfunction has been proposed as one of the major contributor in the pathogenesis 
of the most common neurodegenerative diseases [126]. Nowadays, PD-related genes have already been 
involved in mitochondrial regulation and PD-associated mutations in these genes have been related to 
mitochondrial dysfunction. SNCA (α-synuclein) is linked to familial (autosomal dominant early-onset 
PD) as well as sporadic PD. SNCA aberrant aggregation in oligomers has been shown to be toxic. The 
effect of SNCA oligomerization on mitochondria has been studied in vitro and in vivo and its effects 
include inhibition of mitochondrial complexes, as well as increase in the fragmentation of this organelle 
(Reviewed elsewhere in [127]). Moreover, other two PD-related proteins, PINK1 (PTEN-induced kinase 
1) and Parkin are also involved in mitochondrial regulation, controlling its degradation by mitophagy, a 
selective type of autophagy for degradation of old/damaged mitochondria [127].  Also, cell lines derived 
from PD patients with mutated forms of DJ-1, as well as M17 neuroblastoma cells overexpressing those 
mutants, display aberrations in mitochondrial morphology [128,129]. Finally, fibroblasts derived from 
PD-patients with mutations in LRRK2 (leucine-rich repeat kinase 2), PINK1 and Parkin show clear 
mitochondrial abnormalities [130]. 
As well as the previous organelle, there is a strong evidence supporting the idea that ER stress 
may be an additional mechanism of pathogenesis in PD and other chronic diseases [131].  In this regard, 
SNCA overexpression is able to induce ER stress and promote UPR in rats [132], but also in mice 
overexpressing wild type SNCA and human pathogenic variants, such as A53T [133]. LRRK2 has been 
recently involved in anterograde Golgi transport, and its PD-related mutation R1441C disturbs ER-Golgi 
function [134]. 
To date, there is a little-known about the role of PD-related proteins in the interaction between ER and 
mitochondria. Nonetheless, in this review, the implication of the most studied PARK genes related to 
MAM structure or function is highlighted: 
 
5.1.- α-synuclein (SNCA) 
SNCA (codified by PARK1 and PARK4 genes) is a small soluble protein highly expressed in 
nervous tissues. SNCA aggregates were identified as a major component of Lewy bodies in PD. The 
majority of SNCA is found in soluble form in the cytoplasm. However, under pathologic conditions, 
SNCA binds to lipid membranes and may alter its conformation.  A subpopulation of SNCA is present in 
MAM meanwhile this relationship is perturbed during pathogenic conditions. Mutated forms of this 
protein, such as A30P and A53T, showed lower association with MAMs in M17 cells and in brain of 
transgenic mice overexpressing each of these mutant proteins because of different reasons. A30P 
mutation alters the interaction between SNCA and rafts, meanwhile A53T mutation results in a lower 
amount of SNCA, and, consequently, lower association [135]. Besides, a decrease of ER-mitochondria 
tethering, a mitochondrial fragmentation has been found in these in vitro models [135,136]. In addition, 
SNCA is involved in Ca2+ homeostasis in HeLa cells since its silencing or its aggregation diminish Ca2+ 
uptake to the mitochondria [137]. Moreover, the presence of SNCA and its role in MAMs may influence 
in the cholesterol regulation alterations in PD as a consequence of MAMs dysfunction caused by SNCA 
mutations [135]. 
5.2.- Parkin and PINK1 
Parkin (codified by PARK2 gene) has proved to be a key protein in mitochondrial homeostasis, 
as mentioned above, in association with PINK1 (codified by PARK6 gene) [127]. Impairment of Parkin 
function or activity contributes to neuronal loss in PD models [138]. Under ER stress, Parkin is 
upregulated by the ER stress pathway (PERK/ATF4). This overexpression prevents the ER stress-induced 
mitochondrial damage and confers to the protein Parkin a protective role [139]. This evidence has been 
supported by several cell lines (SH-SY5Y, HEK293T, MEFs) exposed to different ER stressors (TG, L-
histidinol, Tunicamycin) [139]. Interestingly, neuronal toxins, such as MPP+ and 6-OHDA, activate the 
ER-stress response through the activation of PERK and the phosphorylation of eIF2α (eukaryotic 
initiation factor 2α). PERK-elF2α pathway provokes the expression of the transcription factor ATF4 
(activating transcription factor 4) in neuronal PC12 cells [138]. ATF4 possesses a binding site in Parkin 
promotor and enhances its mRNA expression as well as its protein level [139]. Nevertheless, Parkin 
upregulation does not modulate ER stress but do maintain mitochondrial integrity [139]. Although 
mitochondrial toxins increase Parkin mRNA expression level, its endogenous protein level seems to be 
reduced by proteasomal degradation. Thereby, overexpression of ATF4 maintains the Parkin protein level 
reduced by toxins [138]. In this line, Parkin overexpression results in a better maintenance of ER-
mitochondria contact sites and Ca2+ homeostasis in HeLa cells [140]. 
5.3.- DJ-1 
DJ-1 is a protein with a wide variety of functions; its plays an essential role as a redox-dependent 
chaperone, as well as an autophagy modulator. among others [141]. DJ-1 (PARK7) loss-of-function 
mutations are associated with rare forms of inherited early-onset PD and result in oxidative stress-induced 
mitochondrial dysfunction [142,143]. The role of DJ-1 in Ca2+ uptake was studied in 2013 by Ottolini and 
co-workers. Their results showed that DJ-1 downregulation reduces Ca2+ transfer from ER to 
mitochondria, promoting morphological changes in mitochondria and decreasing mitochondrial Ca2+ 
uptake. Therefore, DJ-1 exerts a cytoprotective role maintaining Ca2+ transfer through tethering ER to 
mitochondria. Moreover, its overexpression can counteract p53 effects on mitochondrial deregulation, 
suggesting a great importance of the contact between these organelles to preserve normal physiology 
[144].    
6.- CONCLUSIONS AND FUTURE PERSPECTIVES 
Overall, ER-mitochondria contacts are critical in many cellular processes and signaling pathway. These 
contact sites between ER and mitochondria involved proteins that ensure MAMs structure and/or 
function. MAM formation regulates Ca2+ homeostasis by a reversible mitochondrial movement inhibition. 
Mitochondria are distributed in an space-temporal manner throughout the ER in Ca2+-enriched domains 
and assure Ca2+ uptake [49]. In this regard, we speculate that uncoupling mitochondria failed to 
participate in MAM formation. Thus, for preventing the clearance of damaged mitochondria, 
autophagy/mitophagy inhibition can disrupts the ER-mitochondria tether. Although MAM is important to 
autophagosome formation, it probably exist a bidirectional link between autophagy and MAM. Of note, 
mitochondria contribute to the regulation of ER stress by Ca2+ uptake. Nevertheless, Ca2+ overload in 
mitochondria triggers cell death by cytochrome c release and caspases activation. In AD [6] and HD 
[116], mitochondrial Ca2+ uptake is heightened due to the upregulation of MAM proteins while decrease 
in some models of ALS and PD [144]. It is still unclear how MAM function is either upregulated or 
disrupted in neurodegenerative diseases. 
 
Compelling evidence support the hypothesis that MAMs and their deregulation may play an 
important role in PD pathogenesis, even as an early event [145]. The relationship between PD-related 
proteins, such as SNCA, Parkin and DJ-1, and the ER-mitochondria axis, and how their pathogenic 
mutations alter these interactions, strongly support this idea. In this respect, these findings highlight the 
therapeutic potential of targeting the ER-mitochondria axis. Future studies to determine if other PD-
related genes, such as LRRK2 or GBA (glucoside beta acid), may interfere with the regulation of the 
mitochondria-ER network would be useful to a better understanding of a possible general role of PD-
related proteins in the MAMs, allowing the development of specific therapeutic approaches.  Future 
works in this field will provide a deeper view of the mechanisms underlying the regulation of these 
critical hubs, and how pathogenic situations affect MAMs stability.     
ACRONYMS 
A: amyloid beta. 
ACAT1/SOAT1: Acyl-Coenzyme A: cholesterol acyltransferase 1. 
AD:  Alzheimer’s disease. 
ALS:  Amyotrophic lateral sclerosis. 
APP: amyloid precursor protein. 
ASC: apoptosis-associated speck-like protein.                                                                                                                                                                                                      
ATF6: activating transcription factor 6.                                                                                 
ATG14L: autophagy-related 14-like.                                                                                                 
ATG5: autophagy-related 5.  
BAX: Bcl2-associated X protein.                                                                                                                                                                                
BiP/Grp78: binding immunoglobulin protein/glucose regulated protein 78.                                       
BTN1: battenin CLN3 family protein.                                                                                                          
Ca2+: calcium.                                                                                                                                   
CARDs: Caspase activation and recruitment Domains.                                                      
CHOP: C/EBP homologous protein.                                                                         
CLN3: ceroid-lipofuscinosis neuronal 3.                                                                            
CNX: calnexin.                                                                                                                             
CRT: calreticulin. 
DGAT2: Acyl-CoA: diacylglycerol acyltransferase 2 
DRP1: dynamin-related protein 1.                                                                                                                  
dsRNA: double-stranded RNA.                                                                                                
EGTA:  Ethylene glycol-bis(2-aminoethylether)-N,N,N′,N′-tetraacetic acid                                                                                                                    
eIF2α: eukaryotic initiation factor 2α  
ER: endoplasmic reticulum.                                                                                                                    
ERAD: ER-associated degradation.                                                                                                                  
ERMES: ER-mitochondria encounter structure.  
Ero1: ER oxidoreductase alpha.                                                                                          
FACL4: fatty acid CoA ligase 4.  
Fis1: fission 1 protein.                                                                                                                 
GBA: glucosidase beta acid.                                                                                                                              
Gem1: guanosine tri-phosphatase (GTPase) EF-hand protein of mitochondria 1.                                                                            
GRP75: glucose-regulated protein 75.                                                                                                        
GRP78: glucose-regulated protein 78.                                                                                           
GSK-3β: glycogen synthase kinase-3 beta.                                                                                                                                               
HCV: Hepatitis C virus.                                                                                                                             
HD: HuntingtonHuntington’s disease.                                                                                                      
IFN: interferon.                                                                                                                                             
IL-1β: interleukin-1 .                                                                                                                                             
IL-18: interleukin-18.  
IP3R: inositol-1,4,5-trisphosphate (IP3) receptor  
IRE1: inositol requiring enzyme 1 alpha.  
LONP1: Lon peptidase 1.                                                                                                        
LRRK2: leucine rich repeat kinase 2.                                                                                          
MAM: mitochondria associated-membrane.  
MAVS: mitochondrial antiviral-signaling protein. 
Mdm10: mitochondrial distribution and morphology protein 10.                                               
Mdm12: mitochondrial distribution and morphology protein 12.                                              
Mdm34: mitochondrial distribution and morphology protein 34.                                                  
Mff: mitochondrial fission factor.                                                                                                        
MFN1: mitofusin 1.                                                                                                                                
MFN2: mitofusin 2.                                                                                                          
Miro: mitochondrial Rho GTPase.  
Mmm1: mitochondrial morphology protein 1.  
MSU: monosodium urate.                                                                                                             
mTOR: mammalian Target of Rapamycin                                                                                       
mTORC1: mTOR complex 1.                                                                                               
mTORC2: mTOR complex 2.                                                                                                              
NCL: neuronal ceroid lipofuscinosis.  
NLRP3: NOD-like receptor protein 3 o Nod-like receptor family, pyrin domain containing 3.     
NOD: nucleotide binding oligomerization domain                                                                                                                             
OMM: outer mitochondrial membrane.                                                                             
OMMP: outer mitochondrial membrane permeabilization.                                                  
OPA1: optic atrophy 1.                                                                                                                      
OSBP: oxysterol binding protein.                                                                                         
PACS-2: phosphofurin acidic cluster sorting protein-2.                                                                 
PAMP: pathogen-associated molecular pattern.                                                                                  
PC: phosphatidylcholine.                                                                                                                            
PD: Parkinson’s disease.                                                                                                               
PDI: protein disulfide isomerase.  
PEMT2: phosphatidyl ethanolamine methyltransferase 2.                                                                        
PERK: protein kinase RNA (PKR)-like ER kinase.                                                                                   
PINK1: PTEN-induced putative kinase 1.  
PRR: pattern recognition receptor.                                                                                               
PS: phosphatidylserine.                                                                                                                             
PS-1: Presenilin-1                                                                                                                              
PS-2: Presenilin-2.                                                                                                                                     
PSS1/2: phosphatidylserine synthase-1 and -2.                                                                                                              
PTEN:  phosphatase and tensin homolog.  
PTPIP51: protein tyrosine phosphatase-interacting protein 51.                                                           
Rab1B: member RAS oncogene family 1B.                                                                                
Rab32: member RAS oncogene family 32.                                                                                              
RIG-I: retinoic acid inducible gene I.                                                                                                              
ROS: reactive oxygen species.                                                                                             
SERCA: sarcoendoplasmic reticulum Ca2+ Transport ATPase.                                                       
Sig-1R: sigma-1 receptor.                                                                                                                
SNCA: -synuclein.                                                                                                                                
TDP-43: TAR DNA-binding protein-43.                                                                          
TG: thapsigargin. 
TRIM25: tripartite motif containing 25. 
TRPP2: transient receptor potential protein 2. 
TXNIP: thioredoxin interacting protein. 
UPR: unfolded protein response. 
VAPB: vesicle-associated membrane protein-associated protein-B. 
vCLAMP: vacuole-mitochondrial patch. 
VDAC1: voltage dependent anion channel. 
VTN: vitronectin. 
 
 
REFERENCES 
1. Friedman JR, Lackner LL, West M, DiBenedetto JR, Nunnari J, Voeltz GK (2011) ER tubules mark 
sites of mitochondrial division. Science 334 (6054):358-362. doi:10.1126/science.1207385 
 
2. Shim SH, Xia C, Zhong G, Babcock HP, Vaughan JC, Huang B, Wang X, Xu C, Bi GQ, Zhuang X 
(2012) Super-resolution fluorescence imaging of organelles in live cells with photoswitchable membrane 
probes. Proceedings of the National Academy of Sciences of the United States of America 109 
(35):13978-13983. doi:10.1073/pnas.1201882109 
 
3. Verfaillie T, Rubio N, Garg AD, Bultynck G, Rizzuto R, Decuypere JP, Piette J, Linehan C, Gupta S, 
Samali A, Agostinis P (2012) PERK is required at the ER-mitochondrial contact sites to convey apoptosis 
after ROS-based ER stress. Cell death and differentiation 19 (11):1880-1891. doi:10.1038/cdd.2012.74 
 
4. Hamasaki M, Furuta N, Matsuda A, Nezu A, Yamamoto A, Fujita N, Oomori H, Noda T, Haraguchi T, 
Hiraoka Y, Amano A, Yoshimori T (2013) Autophagosomes form at ER-mitochondria contact sites. 
Nature 495 (7441):389-393. doi:10.1038/nature11910 
 
5. Szabadkai G, Rizzuto R (2013) Kalphalambdaovarsigma kappaalphaiota 
Agammaalphathetaovarsigma: how mitochondrial beauty translates into biological virtue. Current opinion 
in cell biology 25 (4):477-482. doi:10.1016/j.ceb.2013.03.006 
 
6. Area-Gomez E, Del Carmen Lara Castillo M, Tambini MD, Guardia-Laguarta C, de Groof AJ, Madra 
M, Ikenouchi J, Umeda M, Bird TD, Sturley SL, Schon EA (2012) Upregulated function of 
mitochondria-associated ER membranes in Alzheimer disease. The EMBO journal 31 (21):4106-4123. 
doi:10.1038/emboj.2012.202 
 
7. Hedskog L, Pinho CM, Filadi R, Ronnback A, Hertwig L, Wiehager B, Larssen P, Gellhaar S, 
Sandebring A, Westerlund M, Graff C, Winblad B, Galter D, Behbahani H, Pizzo P, Glaser E, 
Ankarcrona M (2013) Modulation of the endoplasmic reticulum-mitochondria interface in Alzheimer's 
disease and related models. Proceedings of the National Academy of Sciences of the United States of 
America 110 (19):7916-7921. doi:10.1073/pnas.1300677110 
 
8. Sheftel AD, Zhang AS, Brown C, Shirihai OS, Ponka P (2007) Direct interorganellar transfer of iron 
from endosome to mitochondrion. Blood 110 (1):125-132. doi:10.1182/blood-2007-01-068148 
 
9. Daniele T, Hurbain I, Vago R, Casari G, Raposo G, Tacchetti C, Schiaffino MV (2014) Mitochondria 
and melanosomes establish physical contacts modulated by Mfn2 and involved in organelle biogenesis. 
Current biology : CB 24 (4):393-403. doi:10.1016/j.cub.2014.01.007 
 
10. Ungermann C (2015) vCLAMPs-an intimate link between vacuoles and mitochondria. Current 
opinion in cell biology 35:30-36. doi:10.1016/j.ceb.2015.03.006 
 
11. Islinger M, Luers GH, Zischka H, Ueffing M, Volkl A (2006) Insights into the membrane proteome 
of rat liver peroxisomes: microsomal glutathione-S-transferase is shared by both subcellular 
compartments. Proteomics 6 (3):804-816. doi:10.1002/pmic.200401347 
 
12. Jourdain I, Sontam D, Johnson C, Dillies C, Hyams JS (2008) Dynamin-dependent biogenesis, cell 
cycle regulation and mitochondrial association of peroxisomes in fission yeast. Traffic 9 (3):353-365. 
doi:10.1111/j.1600-0854.2007.00685.x 
 
13. Neuspiel M, Schauss AC, Braschi E, Zunino R, Rippstein P, Rachubinski RA, Andrade-Navarro MA, 
McBride HM (2008) Cargo-selected transport from the mitochondria to peroxisomes is mediated by 
vesicular carriers. Current biology : CB 18 (2):102-108. doi:10.1016/j.cub.2007.12.038 
 
14. Elbaz-Alon Y, Rosenfeld-Gur E, Shinder V, Futerman AH, Geiger T, Schuldiner M (2014) A 
dynamic interface between vacuoles and mitochondria in yeast. Dev Cell 30 (1):95-102. 
doi:10.1016/j.devcel.2014.06.007 
 
15. Honscher C, Mari M, Auffarth K, Bohnert M, Griffith J, Geerts W, van der Laan M, Cabrera M, 
Reggiori F, Ungermann C (2014) Cellular metabolism regulates contact sites between vacuoles and 
mitochondria. Dev Cell 30 (1):86-94. doi:10.1016/j.devcel.2014.06.006 
 
16. Copeland DE, Dalton AJ (1959) An association between mitochondria and the endoplasmic reticulum 
in cells of the pseudobranch gland of a teleost. The Journal of biophysical and biochemical cytology 5 
(3):393-396 
 
17. Pickett CB, Montisano D, Eisner D, Cascarano J (1980) The physical association between rat liver 
mitochondria and rough endoplasmic reticulum. I. Isolation, electron microscopic examination and 
sedimentation equilibrium centrifugation analyses of rough endoplasmic reticulum-mitochondrial 
complexes. Experimental cell research 128 (2):343-352 
 
18. Montisano DF, Cascarano J, Pickett CB, James TW (1982) Association between mitochondria and 
rough endoplasmic reticulum in rat liver. The Anatomical record 203 (4):441-450. 
doi:10.1002/ar.1092030403 
 
19. Vance JE (1990) Phospholipid synthesis in a membrane fraction associated with mitochondria. The 
Journal of biological chemistry 265 (13):7248-7256 
 
20. McMurray WC, Dawson RM (1969) Phospholipid exchange reactions within the liver cell. The 
Biochemical journal 112 (1):91-108 
 
21. Jungalwala FB, Dawson RM (1970) The origin of mitochondrial phosphatidylcholine within the liver 
cell. European journal of biochemistry / FEBS 12 (2):399-402 
 
22. Sauner MT, Levy M (1971) Study of the transfer of phospholipids from the endoplasmic reticulum to 
the outer and inner mitochondrial membranes. Journal of lipid research 12 (1):71-75 
 
23. Dennis EA, Kennedy EP (1972) Intracellular sites of lipid synthesis and the biogenesis of 
mitochondria. Journal of lipid research 13 (2):263-267 
 24. Stone SJ, Vance JE (2000) Phosphatidylserine synthase-1 and -2 are localized to mitochondria-
associated membranes. The Journal of biological chemistry 275 (44):34534-34540. 
doi:10.1074/jbc.M002865200 
 
25. Cui Z, Vance JE, Chen MH, Voelker DR, Vance DE (1993) Cloning and expression of a novel 
phosphatidylethanolamine N-methyltransferase. A specific biochemical and cytological marker for a 
unique membrane fraction in rat liver. The Journal of biological chemistry 268 (22):16655-16663 
 
26. Rusinol AE, Cui Z, Chen MH, Vance JE (1994) A unique mitochondria-associated membrane 
fraction from rat liver has a high capacity for lipid synthesis and contains pre-Golgi secretory proteins 
including nascent lipoproteins. The Journal of biological chemistry 269 (44):27494-27502 
 
27. Rizzuto R, Pinton P, Carrington W, Fay FS, Fogarty KE, Lifshitz LM, Tuft RA, Pozzan T (1998) 
Close contacts with the endoplasmic reticulum as determinants of mitochondrial Ca2+ responses. Science 
280 (5370):1763-1766 
 
28. Szabadkai G, Simoni AM, Rizzuto R (2003) Mitochondrial Ca2+ uptake requires sustained Ca2+ 
release from the endoplasmic reticulum. The Journal of biological chemistry 278 (17):15153-15161. 
doi:10.1074/jbc.M300180200 
 
29. Szabadkai G, Bianchi K, Varnai P, De Stefani D, Wieckowski MR, Cavagna D, Nagy AI, Balla T, 
Rizzuto R (2006) Chaperone-mediated coupling of endoplasmic reticulum and mitochondrial Ca2+ 
channels. The Journal of cell biology 175 (6):901-911. doi:10.1083/jcb.200608073 
 
30. Boehning D, Patterson RL, Sedaghat L, Glebova NO, Kurosaki T, Snyder SH (2003) Cytochrome c 
binds to inositol (1,4,5) trisphosphate receptors, amplifying calcium-dependent apoptosis. Nature cell 
biology 5 (12):1051-1061. doi:10.1038/ncb1063 
 
31. Cardenas C, Miller RA, Smith I, Bui T, Molgo J, Muller M, Vais H, Cheung KH, Yang J, Parker I, 
Thompson CB, Birnbaum MJ, Hallows KR, Foskett JK (2010) Essential regulation of cell bioenergetics 
by constitutive InsP3 receptor Ca2+ transfer to mitochondria. Cell 142 (2):270-283. 
doi:10.1016/j.cell.2010.06.007 
 
32. Mendes CC, Gomes DA, Thompson M, Souto NC, Goes TS, Goes AM, Rodrigues MA, Gomez MV, 
Nathanson MH, Leite MF (2005) The type III inositol 1,4,5-trisphosphate receptor preferentially 
transmits apoptotic Ca2+ signals into mitochondria. The Journal of biological chemistry 280 (49):40892-
40900. doi:10.1074/jbc.M506623200 
 
33. Rizzuto R, Pozzan T (2006) Microdomains of intracellular Ca2+: molecular determinants and 
functional consequences. Physiological reviews 86 (1):369-408. doi:10.1152/physrev.00004.2005 
 
34. Csordas G, Renken C, Varnai P, Walter L, Weaver D, Buttle KF, Balla T, Mannella CA, Hajnoczky 
G (2006) Structural and functional features and significance of the physical linkage between ER and 
mitochondria. The Journal of cell biology 174 (7):915-921. doi:10.1083/jcb.200604016 
 
35. Kornmann B, Currie E, Collins SR, Schuldiner M, Nunnari J, Weissman JS, Walter P (2009) An ER-
mitochondria tethering complex revealed by a synthetic biology screen. Science 325 (5939):477-481. 
doi:10.1126/science.1175088 
 
36. Murley A, Lackner LL, Osman C, West M, Voeltz GK, Walter P, Nunnari J (2013) ER-associated 
mitochondrial division links the distribution of mitochondria and mitochondrial DNA in yeast. eLife 
2:e00422. doi:10.7554/eLife.00422 
 
37. Wang PT, Garcin PO, Fu M, Masoudi M, St-Pierre P, Pante N, Nabi IR (2015) Distinct mechanisms 
controlling rough and smooth endoplasmic reticulum contacts with mitochondria. Journal of cell science 
128 (15):2759-2765. doi:10.1242/jcs.171132 
 
38. Simmen T, Aslan JE, Blagoveshchenskaya AD, Thomas L, Wan L, Xiang Y, Feliciangeli SF, Hung 
CH, Crump CM, Thomas G (2005) PACS-2 controls endoplasmic reticulum-mitochondria 
communication and Bid-mediated apoptosis. The EMBO journal 24 (4):717-729. 
doi:10.1038/sj.emboj.7600559 
 
39. de Brito OM, Scorrano L (2008) Mitofusin 2 tethers endoplasmic reticulum to mitochondria. Nature 
456 (7222):605-610. doi:10.1038/nature07534 
 
40. Myhill N, Lynes EM, Nanji JA, Blagoveshchenskaya AD, Fei H, Carmine Simmen K, Cooper TJ, 
Thomas G, Simmen T (2008) The subcellular distribution of calnexin is mediated by PACS-2. Molecular 
biology of the cell 19 (7):2777-2788. doi:10.1091/mbc.E07-10-0995 
 
41. Kottgen M, Benzing T, Simmen T, Tauber R, Buchholz B, Feliciangeli S, Huber TB, Schermer B, 
Kramer-Zucker A, Hopker K, Simmen KC, Tschucke CC, Sandford R, Kim E, Thomas G, Walz G (2005) 
Trafficking of TRPP2 by PACS proteins represents a novel mechanism of ion channel regulation. The 
EMBO journal 24 (4):705-716. doi:10.1038/sj.emboj.7600566 
 
42. Filadi R, Greotti E, Turacchio G, Luini A, Pozzan T, Pizzo P (2015) Mitofusin 2 ablation increases 
endoplasmic reticulum-mitochondria coupling. Proceedings of the National Academy of Sciences of the 
United States of America 112 (17):E2174-2181. doi:10.1073/pnas.1504880112 
 
43. Cosson P, Marchetti A, Ravazzola M, Orci L (2012) Mitofusin-2 independent juxtaposition of 
endoplasmic reticulum and mitochondria: an ultrastructural study. PloS one 7 (9):e46293. 
doi:10.1371/journal.pone.0046293 
 
44. De Vos KJ, Morotz GM, Stoica R, Tudor EL, Lau KF, Ackerley S, Warley A, Shaw CE, Miller CC 
(2012) VAPB interacts with the mitochondrial protein PTPIP51 to regulate calcium homeostasis. Human 
molecular genetics 21 (6):1299-1311. doi:10.1093/hmg/ddr559 
 
45. Stoica R, De Vos KJ, Paillusson S, Mueller S, Sancho RM, Lau KF, Vizcay-Barrena G, Lin WL, Xu 
YF, Lewis J, Dickson DW, Petrucelli L, Mitchell JC, Shaw CE, Miller CC (2014) ER-mitochondria 
associations are regulated by the VAPB-PTPIP51 interaction and are disrupted by ALS/FTD-associated 
TDP-43. Nature communications 5:3996. doi:10.1038/ncomms4996 
 
46. Huttlin EL, Ting L, Bruckner RJ, Gebreab F, Gygi MP, Szpyt J, Tam S, Zarraga G, Colby G, Baltier 
K, Dong R, Guarani V, Vaites LP, Ordureau A, Rad R, Erickson BK, Wuhr M, Chick J, Zhai B, 
Kolippakkam D, Mintseris J, Obar RA, Harris T, Artavanis-Tsakonas S, Sowa ME, De Camilli P, Paulo 
JA, Harper JW, Gygi SP (2015) The BioPlex Network: A Systematic Exploration of the Human 
Interactome. Cell 162 (2):425-440. doi:10.1016/j.cell.2015.06.043 
 
47. Mizuno K, Padma P, Konno A, Satouh Y, Ogawa K, Inaba K (2009) A novel neuronal calcium sensor 
family protein, calaxin, is a potential Ca(2+)-dependent regulator for the outer arm dynein of metazoan 
cilia and flagella. Biology of the cell / under the auspices of the European Cell Biology Organization 101 
(2):91-103. doi:10.1042/BC20080032 
 
48. Vinogradova MV, Malanina GG, Reddy AS, Fletterick RJ (2009) Structure of the complex of a 
mitotic kinesin with its calcium binding regulator. Proceedings of the National Academy of Sciences of 
the United States of America 106 (20):8175-8179. doi:10.1073/pnas.0811131106 
 
49. Yi M, Weaver D, Hajnoczky G (2004) Control of mitochondrial motility and distribution by the 
calcium signal: a homeostatic circuit. The Journal of cell biology 167 (4):661-672. doi:jcb.200406038 
[pii]10.1083/jcb.200406038 
50. Pizzo P, Pozzan T (2007) Mitochondria-endoplasmic reticulum choreography: structure and signaling 
dynamics. Trends in cell biology 17 (10):511-517. doi:S0962-8924(07)00170-5 
[pii]10.1016/j.tcb.2007.07.011 
51. Saotome M, Safiulina D, Szabadkai G, Das S, Fransson A, Aspenstrom P, Rizzuto R, Hajnoczky G 
(2008) Bidirectional Ca2+-dependent control of mitochondrial dynamics by the Miro GTPase. 
Proceedings of the National Academy of Sciences of the United States of America 105 (52):20728-
20733. doi:10.1073/pnas.0808953105 [pii] 
52. Fransson S, Ruusala A, Aspenstrom P (2006) The atypical Rho GTPases Miro-1 and Miro-2 have 
essential roles in mitochondrial trafficking. Biochem Biophys Res Commun 344 (2):500-510. doi:S0006-
291X(06)00696-6 [pii]10.1016/j.bbrc.2006.03.163 
53. Chen H, Detmer SA, Ewald AJ, Griffin EE, Fraser SE, Chan DC (2003) Mitofusins Mfn1 and Mfn2 
coordinately regulate mitochondrial fusion and are essential for embryonic development. The Journal of 
cell biology 160 (2):189-200. doi:10.1083/jcb.200211046 jcb.200211046 [pii] 
54. Youle RJ, van der Bliek AM (2012) Mitochondrial fission, fusion, and stress. Science 337 
(6098):1062-1065. doi:10.1126/science.1219855 337/6098/1062 [pii] 
55. Hoppins S, Nunnari J (2012) Cell Biology. Mitochondrial dynamics and apoptosis--the ER 
connection. Science 337 (6098):1052-1054. doi:10.1126/science.1224709 337/6098/1052 [pii] 
56. Loson OC, Song Z, Chen H, Chan DC (2013) Fis1, Mff, MiD49, and MiD51 mediate Drp1 
recruitment in mitochondrial fission. Molecular biology of the cell 24 (5):659-667. doi:10.1091/mbc.E12-
10-0721 
 
57. Arasaki K, Shimizu H, Mogari H, Nishida N, Hirota N, Furuno A, Kudo Y, Baba M, Baba N, Cheng 
J, Fujimoto T, Ishihara N, Ortiz-Sandoval C, Barlow LD, Raturi A, Dohmae N, Wakana Y, Inoue H, Tani 
K, Dacks JB, Simmen T, Tagaya M (2015) A role for the ancient SNARE syntaxin 17 in regulating 
mitochondrial division. Dev Cell 32 (3):304-317. doi:10.1016/j.devcel.2014.12.011 
 
58. Klionsky DJ, Abdalla FC, Abeliovich H, Abraham RT, Acevedo-Arozena A, Adeli K, Agholme L, 
Agnello M, Agostinis P, Aguirre-Ghiso JA et al. (2012) Guidelines for the use and interpretation of 
assays for monitoring autophagy. Autophagy 8 (4):445-544 
 
59. Axe EL, Walker SA, Manifava M, Chandra P, Roderick HL, Habermann A, Griffiths G, Ktistakis NT 
(2008) Autophagosome formation from membrane compartments enriched in phosphatidylinositol 3-
phosphate and dynamically connected to the endoplasmic reticulum. The Journal of cell biology 182 
(4):685-701. doi:10.1083/jcb.200803137 
 
60. Ge L, Melville D, Zhang M, Schekman R (2013) The ER-Golgi intermediate compartment is a key 
membrane source for the LC3 lipidation step of autophagosome biogenesis. eLife 2:e00947. 
doi:10.7554/eLife.00947 
 
61. Hailey DW, Rambold AS, Satpute-Krishnan P, Mitra K, Sougrat R, Kim PK, Lippincott-Schwartz J 
(2010) Mitochondria supply membranes for autophagosome biogenesis during starvation. Cell 141 
(4):656-667. doi:10.1016/j.cell.2010.04.009 
 
62. Ravikumar B, Moreau K, Rubinsztein DC (2010) Plasma membrane helps autophagosomes grow. 
Autophagy 6 (8):1184-1186. doi:10.4161/auto.6.8.13428 
 
63. Bockler S, Westermann B (2014) ER-mitochondria contacts as sites of mitophagosome formation. 
Autophagy 10 (7):1346-1347. doi:10.4161/auto.28981 
 
64. Rodriguez-Enriquez S, Kim I, Currin RT, Lemasters JJ (2006) Tracker dyes to probe mitochondrial 
autophagy (mitophagy) in rat hepatocytes. Autophagy 2 (1):39-46 
 
65. Wullschleger S, Loewith R, Hall MN (2006) TOR signaling in growth and metabolism. Cell 124 
(3):471-484. doi:S0092-8674(06)00108-5 [pii]10.1016/j.cell.2006.01.016 
66. Betz C, Stracka D, Prescianotto-Baschong C, Frieden M, Demaurex N, Hall MN (2013) Feature 
Article: mTOR complex 2-Akt signaling at mitochondria-associated endoplasmic reticulum membranes 
(MAM) regulates mitochondrial physiology. Proceedings of the National Academy of Sciences of the 
United States of America 110 (31):12526-12534. doi:10.1073/pnas.1302455110 
 
67. Somlyo AP (1984) Cell physiology: cellular site of calcium regulation. Nature 309 (5968):516-517 
 
68. Giacomello M, Drago I, Bortolozzi M, Scorzeto M, Gianelle A, Pizzo P, Pozzan T (2010) Ca2+ hot 
spots on the mitochondrial surface are generated by Ca2+ mobilization from stores, but not by activation 
of store-operated Ca2+ channels. Molecular cell 38 (2):280-290. doi:10.1016/j.molcel.2010.04.003 
 
69. Michalak M, Robert Parker JM, Opas M (2002) Ca2+ signaling and calcium binding chaperones of 
the endoplasmic reticulum. Cell Calcium 32 (5-6):269-278. doi:S0143416002001884 [pii] 
 
70. Joseph SK, Boehning D, Bokkala S, Watkins R, Widjaja J (1999) Biosynthesis of inositol 
trisphosphate receptors: selective association with the molecular chaperone calnexin. The Biochemical 
journal 342 ( Pt 1):153-161 
 
71. John LM, Lechleiter JD, Camacho P (1998) Differential modulation of SERCA2 isoforms by 
calreticulin. The Journal of cell biology 142 (4):963-973 
 
72. Lynes EM, Raturi A, Shenkman M, Ortiz Sandoval C, Yap MC, Wu J, Janowicz A, Myhill N, Benson 
MD, Campbell RE, Berthiaume LG, Lederkremer GZ, Simmen T (2013) Palmitoylation is the switch that 
assigns calnexin to quality control or ER Ca2+ signaling. Journal of cell science 126 (Pt 17):3893-3903. 
doi:10.1242/jcs.125856jcs.125856 [pii] 
73. Hayashi T, Su TP (2007) Sigma-1 receptor chaperones at the ER-mitochondrion interface regulate 
Ca(2+) signaling and cell survival. Cell 131 (3):596-610. doi:S0092-8674(07)01099-9 
[pii]10.1016/j.cell.2007.08.036 
74. Keinan N, Pahima H, Ben-Hail D, Shoshan-Barmatz V (2013) The role of calcium in VDAC1 
oligomerization and mitochondria-mediated apoptosis. Biochim Biophys Acta 1833 (7):1745-1754. 
doi:10.1016/j.bbamcr.2013.03.017 
 
75. Rapizzi E, Pinton P, Szabadkai G, Wieckowski MR, Vandecasteele G, Baird G, Tuft RA, Fogarty KE, 
Rizzuto R (2002) Recombinant expression of the voltage-dependent anion channel enhances the transfer 
of Ca2+ microdomains to mitochondria. The Journal of cell biology 159 (4):613-624. 
doi:10.1083/jcb.200205091 
 
76. Gellerich FN, Gizatullina Z, Trumbeckaite S, Nguyen HP, Pallas T, Arandarcikaite O, Vielhaber S, 
Seppet E, Striggow F (2010) The regulation of OXPHOS by extramitochondrial calcium. Biochim 
Biophys Acta 1797 (6-7):1018-1027. doi:10.1016/j.bbabio.2010.02.005 S0005-2728(10)00051-4 [pii] 
77. Bononi A, Bonora M, Marchi S, Missiroli S, Poletti F, Giorgi C, Pandolfi PP, Pinton P (2013) 
Identification of PTEN at the ER and MAMs and its regulation of Ca(2+) signaling and apoptosis in a 
protein phosphatase-dependent manner. Cell death and differentiation 20 (12):1631-1643. 
doi:10.1038/cdd.2013.77 
 
78. Harding HP, Zhang Y, Ron D (1999) Protein translation and folding are coupled by an endoplasmic-
reticulum-resident kinase. Nature 397 (6716):271-274. doi:10.1038/16729 
 
79. Wang XZ, Harding HP, Zhang Y, Jolicoeur EM, Kuroda M, Ron D (1998) Cloning of mammalian 
Ire1 reveals diversity in the ER stress responses. The EMBO journal 17 (19):5708-5717. 
doi:10.1093/emboj/17.19.5708 
 
80. Shen J, Chen X, Hendershot L, Prywes R (2002) ER stress regulation of ATF6 localization by 
dissociation of BiP/GRP78 binding and unmasking of Golgi localization signals. Developmental cell 3 
(1):99-111 
 
81. Schröder M, Kaufman RJ (2005) The mammalian unfolded protein response. Annual review of 
biochemistry 74 (1):739-789. doi:10.1146/annurev.biochem.73.011303.074134 
 
82. Tu BP, Weissman JS (2004) Oxidative protein folding in eukaryotes: mechanisms and consequences. 
The Journal of cell biology 164 (3):341-346. doi:10.1083/jcb.200311055 
 
83. Bravo R, Vicencio JM, Parra V, Troncoso R, Munoz JP, Bui M, Quiroga C, Rodriguez AE, Verdejo 
HE, Ferreira J, Iglewski M, Chiong M, Simmen T, Zorzano A, Hill JA, Rothermel BA, Szabadkai G, 
Lavandero S (2011) Increased ER-mitochondrial coupling promotes mitochondrial respiration and 
bioenergetics during early phases of ER stress. Journal of cell science 124 (Pt 13):2143-2152. 
doi:10.1242/jcs.080762 
 
84. Verfaillie T, Rubio N, Garg AD, Bultynck G, Rizzuto R, Decuypere J-P, Piette J, Linehan C, Gupta S, 
Samali A, Agostinis P (2012) PERK is required at the ER-mitochondrial contact sites to convey apoptosis 
after ROS-based ER stress. Cell death and differentiation 19 (11):1880-1891. doi:10.1038/cdd.2012.74 
 
85. Munoz JP, Ivanova S, Sánchez-Wandelmer J, Martínez-Cristóbal P, Noguera E, Sancho A, Díaz-
Ramos A, Hernández-Alvarez MI, Sebastián D, Mauvezin C, Palacín M, Zorzano A (2013) Mfn2 
modulates the UPR and mitochondrial function via repression of PERK. The EMBO journal 32 
(17):2348-2361. doi:10.1038/emboj.2013.168 
 
86. Lièvremont JP, Rizzuto R, Hendershot L, Meldolesi J (1997) BiP, a major chaperone protein of the 
endoplasmic reticulum lumen, plays a direct and important role in the storage of the rapidly exchanging 
pool of Ca2+. The Journal of biological chemistry 272 (49):30873-30879 
 
87. Hayashi T, Su T-P (2007) Sigma-1 receptor chaperones at the ER-mitochondrion interface regulate 
Ca(2+) signaling and cell survival. Cell 131 (3):596-610. doi:10.1016/j.cell.2007.08.036 
 
88. Lynes EM, Bui M, Yap MC, Benson MD, Schneider B, Ellgaard L, Berthiaume LG, Simmen T 
(2012) Palmitoylated TMX and calnexin target to the mitochondria-associated membrane. The EMBO 
journal 31 (2):457-470. doi:10.1038/emboj.2011.384 
 
89. Myhill N, Lynes EM, Nanji JA, Blagoveshchenskaya AD, Fei H, Carmine Simmen K, Cooper TJ, 
Thomas G, Simmen T (2008) The subcellular distribution of calnexin is mediated by PACS-2. Molecular 
biology of the cell 19 (7):2777-2788. doi:10.1091/mbc.E07-10-0995 
 
90. Gilady SY, Bui M, Lynes EM, Benson MD, Watts R, Vance JE, Simmen T (2010) Ero1alpha requires 
oxidizing and normoxic conditions to localize to the mitochondria-associated membrane (MAM). Cell 
stress &amp; chaperones 15 (5):619-629. doi:10.1007/s12192-010-0174-1 
 
91. Anelli T, Bergamelli L, Margittai E, Rimessi A, Fagioli C, Malgaroli A, Pinton P, Ripamonti M, 
Rizzuto R, Sitia R (2012) Ero1α regulates Ca(2+) fluxes at the endoplasmic reticulum-mitochondria 
interface (MAM). Antioxidants &amp; redox signaling 16 (10):1077-1087. doi:10.1089/ars.2011.4004 
 
92. Zhou R, Yazdi AS, Menu P, Tschopp J (2011) A role for mitochondria in NLRP3 inflammasome 
activation. Nature 469 (7329):221-225. doi:10.1038/nature09663 
93. Schroder K, Tschopp J (2010) The inflammasomes. Cell 140 (6):821-832. 
doi:10.1016/j.cell.2010.01.040 S0092-8674(10)00075-9 [pii] 
94. Franchi L, Munoz-Planillo R, Reimer T, Eigenbrod T, Nunez G (2010) Inflammasomes as microbial 
sensors. Eur J Immunol 40 (3):611-615. doi:10.1002/eji.200940180 
 
95. Jin C, Flavell RA (2010) Molecular mechanism of NLRP3 inflammasome activation. Journal of 
clinical immunology 30 (5):628-631. doi:10.1007/s10875-010-9440-3 
 
96. Dostert C, Petrilli V, Van Bruggen R, Steele C, Mossman BT, Tschopp J (2008) Innate immune 
activation through Nalp3 inflammasome sensing of asbestos and silica. Science 320 (5876):674-677. 
doi:10.1126/science.1156995 
 
97. Zhang X, Zhang JH, Chen XY, Hu QH, Wang MX, Jin R, Zhang QY, Wang W, Wang R, Kang LL, 
Li JS, Li M, Pan Y, Huang JJ, Kong LD (2015) Reactive oxygen species-induced TXNIP drives fructose-
mediated hepatic inflammation and lipid accumulation through NLRP3 inflammasome activation. 
Antioxidants & redox signaling 22 (10):848-870. doi:10.1089/ars.2014.5868 
 
98. Saxena G, Chen J, Shalev A (2010) Intracellular shuttling and mitochondrial function of thioredoxin-
interacting protein. The Journal of biological chemistry 285 (6):3997-4005. 
doi:10.1074/jbc.M109.034421 
99. Yoneyama M, Kikuchi M, Natsukawa T, Shinobu N, Imaizumi T, Miyagishi M, Taira K, Akira S, 
Fujita T (2004) The RNA helicase RIG-I has an essential function in double-stranded RNA-induced 
innate antiviral responses. Nature immunology 5 (7):730-737. doi:10.1038/ni1087 
 
100. Gack MU, Shin YC, Joo C-H, Urano T, Liang C, Sun L, Takeuchi O, Akira S, Chen Z, Inoue S, 
Jung JU (2007) TRIM25 RING-finger E3 ubiquitin ligase is essential for RIG-I-mediated antiviral 
activity. Nature 446 (7138):916-920. doi:10.1038/nature05732 
 
101. Renauld J-C (2003) Class II cytokine receptors and their ligands: key antiviral and inflammatory 
modulators. Nature reviews Immunology 3 (8):667-676. doi:10.1038/nri1153 
 
102. Kumar H, Kawai T, Kato H, Sato S, Takahashi K, Coban C, Yamamoto M, Uematsu S, Ishii KJ, 
Takeuchi O, Akira S (2006) Essential role of IPS-1 in innate immune responses against RNA viruses. The 
Journal of experimental medicine 203 (7):1795-1803. doi:10.1084/jem.20060792 
 
103. Dixit E, Boulant S, Zhang Y, Lee ASY, Odendall C, Shum B, Hacohen N, Chen ZJ, Whelan SP, 
Fransen M, Nibert ML, Superti-Furga G, Kagan JC (2010) Peroxisomes are signaling platforms for 
antiviral innate immunity. Cell 141 (4):668-681. doi:10.1016/j.cell.2010.04.018 
 
104. Seth RB, Sun L, Ea C-K, Chen ZJ (2005) Identification and characterization of MAVS, a 
mitochondrial antiviral signaling protein that activates NF-kappaB and IRF 3. Cell 122 (5):669-682. 
doi:10.1016/j.cell.2005.08.012 
 
105. Horner SM, Liu HM, Park HS, Briley J, Gale M (2011) Mitochondrial-associated endoplasmic 
reticulum membranes (MAM) form innate immune synapses and are targeted by hepatitis C virus. 
Proceedings of the National Academy of Sciences of the United States of America 108 (35):14590-
14595. doi:10.1073/pnas.1110133108 
 
106. Saito T, Owen DM, Jiang F, Marcotrigiano J, Gale M (2008) Innate immunity induced by 
composition-dependent RIG-I recognition of hepatitis C virus RNA. Nature 454 (7203):523-527. 
doi:10.1038/nature07106 
 
107. Meylan E, Curran J, Hofmann K, Moradpour D, Binder M, Bartenschlager R, Tschopp J (2005) 
Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus. Nature 437 
(7062):1167-1172. doi:10.1038/nature04193 
 
108. Horner SM (2014) Activation and evasion of antiviral innate immunity by hepatitis C virus. Journal 
of molecular biology 426 (6):1198-1209. doi:10.1016/j.jmb.2013.10.032 
 
109. Horner SM, Wilkins C, Badil S, Iskarpatyoti J, Gale M (2015) Proteomic analysis of mitochondrial-
associated ER membranes (MAM) during RNA virus infection reveals dynamic changes in protein and 
organelle trafficking. PloS one 10 (3):e0117963. doi:10.1371/journal.pone.0117963 
 
110. Vance DE, Walkey CJ, Cui Z (1997) Phosphatidylethanolamine N-methyltransferase from liver. 
Biochim Biophys Acta 1348 (1-2):142-150 
 
111. Gaigg B, Simbeni R, Hrastnik C, Paltauf F, Daum G (1995) Characterization of a microsomal 
subfraction associated with mitochondria of the yeast, Saccharomyces cerevisiae. Involvement in 
synthesis and import of phospholipids into mitochondria. Biochim Biophys Acta 1234 (2):214-220 
 
112. Stone SJ, Levin MC, Zhou P, Han J, Walther TC, Farese RV, Jr. (2009) The endoplasmic reticulum 
enzyme DGAT2 is found in mitochondria-associated membranes and has a mitochondrial targeting signal 
that promotes its association with mitochondria. The Journal of biological chemistry 284 (8):5352-5361. 
doi:10.1074/jbc.M805768200 
 
113. Lewin TM, Kim JH, Granger DA, Vance JE, Coleman RA (2001) Acyl-CoA synthetase isoforms 1, 
4, and 5 are present in different subcellular membranes in rat liver and can be inhibited independently. 
The Journal of biological chemistry 276 (27):24674-24679. doi:10.1074/jbc.M102036200 
 
114. Area-Gomez E, de Groof AJ, Boldogh I, Bird TD, Gibson GE, Koehler CM, Yu WH, Duff KE, 
Yaffe MP, Pon LA, Schon EA (2009) Presenilins are enriched in endoplasmic reticulum membranes 
associated with mitochondria. The American journal of pathology 175 (5):1810-1816. 
doi:10.2353/ajpath.2009.090219 
 
115. Jansen KL, Faull RL, Storey P, Leslie RA (1993) Loss of sigma binding sites in the CA1 area of the 
anterior hippocampus in Alzheimer's disease correlates with CA1 pyramidal cell loss. Brain research 623 
(2):299-302 
 
116. Hyrskyluoto A, Pulli I, Tornqvist K, Ho TH, Korhonen L, Lindholm D (2013) Sigma-1 receptor 
agonist PRE084 is protective against mutant huntingtin-induced cell degeneration: involvement of 
calpastatin and the NF-kappaB pathway. Cell death & disease 4:e646. doi:10.1038/cddis.2013.170 
 
117. Al-Saif A, Al-Mohanna F, Bohlega S (2011) A mutation in sigma-1 receptor causes juvenile 
amyotrophic lateral sclerosis. Annals of neurology 70 (6):913-919. doi:10.1002/ana.22534 
 
118. Moustaqim-Barrette A, Lin YQ, Pradhan S, Neely GG, Bellen HJ, Tsuda H (2014) The amyotrophic 
lateral sclerosis 8 protein, VAP, is required for ER protein quality control. Human molecular genetics 23 
(8):1975-1989. doi:10.1093/hmg/ddt594 
 
119. Atwal RS, Xia J, Pinchev D, Taylor J, Epand RM, Truant R (2007) Huntingtin has a membrane 
association signal that can modulate huntingtin aggregation, nuclear entry and toxicity. Human molecular 
genetics 16 (21):2600-2615. doi:10.1093/hmg/ddm217 
 
120. Reijonen S, Putkonen N, Norremolle A, Lindholm D, Korhonen L (2008) Inhibition of endoplasmic 
reticulum stress counteracts neuronal cell death and protein aggregation caused by N-terminal mutant 
huntingtin proteins. Experimental cell research 314 (5):950-960. doi:10.1016/j.yexcr.2007.12.025 
 
121. Mishina M, Ohyama M, Ishii K, Kitamura S, Kimura Y, Oda K, Kawamura K, Sasaki T, Kobayashi 
S, Katayama Y, Ishiwata K (2008) Low density of sigma1 receptors in early Alzheimer's disease. Annals 
of nuclear medicine 22 (3):151-156. doi:10.1007/s12149-007-0094-z 
 
122. Mishina M, Ishiwata K, Ishii K, Kitamura S, Kimura Y, Kawamura K, Oda K, Sasaki T, Sakayori O, 
Hamamoto M, Kobayashi S, Katayama Y (2005) Function of sigma1 receptors in Parkinson's disease. 
Acta neurologica Scandinavica 112 (2):103-107. doi:10.1111/j.1600-0404.2005.00432.x 
 
123. Duennwald ML, Lindquist S (2008) Impaired ERAD and ER stress are early and specific events in 
polyglutamine toxicity. Genes & development 22 (23):3308-3319. doi:10.1101/gad.1673408 
 
124. Kyttala A, Ihrke G, Vesa J, Schell MJ, Luzio JP (2004) Two motifs target Batten disease protein 
CLN3 to lysosomes in transfected nonneuronal and neuronal cells. Molecular biology of the cell 15 
(3):1313-1323. doi:10.1091/mbc.E03-02-0120 
 
125. Padilla-Lopez S, Langager D, Chan CH, Pearce DA (2012) BTN1, the Saccharomyces cerevisiae 
homolog to the human Batten disease gene, is involved in phospholipid distribution. Disease models & 
mechanisms 5 (2):191-199. doi:10.1242/dmm.008490 
 
126. Schon EA, Przedborski S (2011) Mitochondria: the next (neurode)generation. Neuron 70 (6):1033-
1053. doi:10.1016/j.neuron.2011.06.003 
 
127. Ryan BJ, Hoek S, Fon EA, Wade-Martins R (2015) Mitochondrial dysfunction and mitophagy in 
Parkinson's: from familial to sporadic disease. Trends in biochemical sciences 40 (4):200-210. 
doi:10.1016/j.tibs.2015.02.003 
 
128. Irrcher I, Aleyasin H, Seifert EL, Hewitt SJ, Chhabra S, Phillips M, Lutz AK, Rousseaux MW, 
Bevilacqua L, Jahani-Asl A, Callaghan S, MacLaurin JG, Winklhofer KF, Rizzu P, Rippstein P, Kim RH, 
Chen CX, Fon EA, Slack RS, Harper ME, McBride HM, Mak TW, Park DS (2010) Loss of the 
Parkinson's disease-linked gene DJ-1 perturbs mitochondrial dynamics. Human molecular genetics 19 
(19):3734-3746. doi:10.1093/hmg/ddq288 
 
129. Wang X, Petrie TG, Liu Y, Liu J, Fujioka H, Zhu X (2012) Parkinson's disease-associated DJ-1 
mutations impair mitochondrial dynamics and cause mitochondrial dysfunction. Journal of 
neurochemistry 121 (5):830-839. doi:10.1111/j.1471-4159.2012.07734.x 
 
130. Smith GA, Jansson J, Rocha EM, Osborn T, Hallett PJ, Isacson O (2015) Fibroblast Biomarkers of 
Sporadic Parkinson's Disease and LRRK2 Kinase Inhibition. Molecular neurobiology. 
doi:10.1007/s12035-015-9435-4 
 
131. Ozcan L, Tabas I (2012) Role of endoplasmic reticulum stress in metabolic disease and other 
disorders. Annual review of medicine 63:317-328. doi:10.1146/annurev-med-043010-144749 
 
132. Gorbatyuk MS, Shabashvili A, Chen W, Meyers C, Sullivan LF, Salganik M, Lin JH, Lewin AS, 
Muzyczka N, Gorbatyuk OS (2012) Glucose regulated protein 78 diminishes alpha-synuclein 
neurotoxicity in a rat model of Parkinson disease. Molecular therapy : the journal of the American 
Society of Gene Therapy 20 (7):1327-1337. doi:10.1038/mt.2012.28 
 
133. Colla E, Coune P, Liu Y, Pletnikova O, Troncoso JC, Iwatsubo T, Schneider BL, Lee MK (2012) 
Endoplasmic reticulum stress is important for the manifestations of alpha-synucleinopathy in vivo. The 
Journal of neuroscience : the official journal of the Society for Neuroscience 32 (10):3306-3320. 
doi:10.1523/JNEUROSCI.5367-11.2012 
 
134. Cho HJ, Yu J, Xie C, Rudrabhatla P, Chen X, Wu J, Parisiadou L, Liu G, Sun L, Ma B, Ding J, Liu 
Z, Cai H (2014) Leucine-rich repeat kinase 2 regulates Sec16A at ER exit sites to allow ER-Golgi export. 
The EMBO journal 33 (20):2314-2331. doi:10.15252/embj.201487807 
 
135. Guardia-Laguarta C, Area-Gomez E, Rub C, Liu Y, Magrane J, Becker D, Voos W, Schon EA, 
Przedborski S (2014) alpha-Synuclein is localized to mitochondria-associated ER membranes. The 
Journal of neuroscience : the official journal of the Society for Neuroscience 34 (1):249-259. 
doi:10.1523/JNEUROSCI.2507-13.2014 
 
136. Guardia-Laguarta C, Area-Gomez E, Schon EA, Przedborski S (2015) A new role for alpha-
synuclein in Parkinson's disease: Alteration of ER-mitochondrial communication. Movement disorders : 
official journal of the Movement Disorder Society 30 (8):1026-1033. doi:10.1002/mds.26239 
 
137. Cali T, Ottolini D, Negro A, Brini M (2012) alpha-Synuclein controls mitochondrial calcium 
homeostasis by enhancing endoplasmic reticulum-mitochondria interactions. The Journal of biological 
chemistry 287 (22):17914-17929. doi:10.1074/jbc.M111.302794 
 
138. Sun X, Liu J, Crary JF, Malagelada C, Sulzer D, Greene LA, Levy OA (2013) ATF4 protects against 
neuronal death in cellular Parkinson's disease models by maintaining levels of parkin. The Journal of 
neuroscience : the official journal of the Society for Neuroscience 33 (6):2398-2407. 
doi:10.1523/JNEUROSCI.2292-12.2013 
 
139. Bouman L, Schlierf A, Lutz AK, Shan J, Deinlein A, Kast J, Galehdar Z, Palmisano V, Patenge N, 
Berg D, Gasser T, Augustin R, Trumbach D, Irrcher I, Park DS, Wurst W, Kilberg MS, Tatzelt J, 
Winklhofer KF (2011) Parkin is transcriptionally regulated by ATF4: evidence for an interconnection 
between mitochondrial stress and ER stress. Cell death and differentiation 18 (5):769-782. 
doi:10.1038/cdd.2010.142 
 
140. Cali T, Ottolini D, Negro A, Brini M (2013) Enhanced parkin levels favor ER-mitochondria 
crosstalk and guarantee Ca(2+) transfer to sustain cell bioenergetics. Biochim Biophys Acta 1832 
(4):495-508. doi:10.1016/j.bbadis.2013.01.004 
 
141. Duplan E, Giaime E, Viotti J, Sevalle J, Corti O, Brice A, Ariga H, Qi L, Checler F, Alves da Costa 
C (2013) ER-stress-associated functional link between Parkin and DJ-1 via a transcriptional cascade 
involving the tumor suppressor p53 and the spliced X-box binding protein XBP-1. Journal of cell science 
126 (Pt 9):2124-2133. doi:10.1242/jcs.127340 
 
142. Bonifati V, Rizzu P, van Baren MJ, Schaap O, Breedveld GJ, Krieger E, Dekker MC, Squitieri F, 
Ibanez P, Joosse M, van Dongen JW, Vanacore N, van Swieten JC, Brice A, Meco G, van Duijn CM, 
Oostra BA, Heutink P (2003) Mutations in the DJ-1 gene associated with autosomal recessive early-onset 
parkinsonism. Science 299 (5604):256-259. doi:10.1126/science.1077209 
 
143. Yokota T, Sugawara K, Ito K, Takahashi R, Ariga H, Mizusawa H (2003) Down regulation of DJ-1 
enhances cell death by oxidative stress, ER stress, and proteasome inhibition. Biochem Biophys Res 
Commun 312 (4):1342-1348 
 
144. Ottolini D, Cali T, Negro A, Brini M (2013) The Parkinson disease-related protein DJ-1 counteracts 
mitochondrial impairment induced by the tumour suppressor protein p53 by enhancing endoplasmic 
reticulum-mitochondria tethering. Human molecular genetics 22 (11):2152-2168. 
doi:10.1093/hmg/ddt068 
 
145. Guardia-Laguarta C, Area-Gomez E, Schon EA, Przedborski S (2015) Novel subcellular localization 
for alpha-synuclein: possible functional consequences. Frontiers in neuroanatomy 9:17. 
doi:10.3389/fnana.2015.00017 
 
 
 
 
 
 
Figure 1. Mitochondrial-associated ER-membranes (MAMs) and neurodegenerative 
disorders. A. Schematic illustration of structural MAM’s network proteins B. Localized events 
in MAMs that contribute to the pathogenesis of neurodegenerative diseases, i.e., elevated 
activity of presenilin-1 (PS1) in MAMs in connection with the Alzheimer’s disease; Loss of 
function of sigma-1 receptor (Sig-1R) defective or interaction between vesicle-associated 
membrane protein-associated protein B (VAPB) and protein tyrosine phosphatase-interacting 
protein 51 (PTPIP51) in relation to Amyotrophic lateral sclerosis; mutations in huntingtin 
(HTT) linked to Huntington’s disease; or dysfunction on proteins present in MAMs (as α-
synuclein, Parkin or DJ-1) correlates also with the Parkinson’s disease. Aβ, amyloid-β; Ca2+,, 
calcium; ER, endoplasmic reticulum; GPR75, glucose-regulated protein 75; IP3R, inositol-
1,4,5-trisphosphate (IP3) receptor; MFN, mitofusin; PACS-2, phosphofurin acidic cluster 
sorting protein-2a-syn; poly-Q, polyglutamine; TRP, transient receptor potential channel; 
VDAC1, mitochondrial voltage-dependent anion channel isoform 1. 
 
